You can find the annual or quarterly income statement of Aardvark Therapeutics Inc here for insights into the performance and operational efficiency of Aardvark Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

Operating expenses

247.73%17.70M

160.96%15.85M

382.27%10.47M

323.20%9.45M

196.16%5.09M

--6.07M

--2.17M

--2.23M

--1.72M

R&D expenses

237.93%13.74M

226.26%13.14M

518.42%7.75M

424.53%8.06M

321.68%4.07M

--4.03M

--1.25M

--1.54M

--964.00K

Depreciation, depletion, and amortization

25.00%10.00K

--11.00K

150.00%5.00K

-68.00%8.00K

-69.23%8.00K

----

--2.00K

--25.00K

--26.00K

Other operating expenses

----

--0.00

----

---47.00K

----

Operating profit

-247.73%-17.70M

-160.96%-15.85M

-382.27%-10.47M

-323.20%-9.45M

-196.16%-5.09M

---6.07M

---2.17M

---2.23M

---1.72M

Net non-operating interest income (expenses)

Non-operating interest income

35.10%1.35M

150.51%1.49M

1040.78%1.18M

507.63%717.00K

640.74%1.00M

--594.00K

--103.00K

--118.00K

--135.00K

Gains from sale of securities

139.56%36.00K

-123.33%-7.00K

86.36%-15.00K

-162.16%-46.00K

82.67%-91.00K

--30.00K

---110.00K

--74.00K

---525.00K

Income before tax

-290.15%-16.32M

-163.66%-14.37M

-327.46%-9.31M

-330.13%-8.78M

-98.29%-4.18M

---5.45M

---2.18M

---2.04M

---2.11M

Income tax

----

--0.00

----

--0.00

Income after tax

-290.15%-16.32M

-163.66%-14.37M

-327.46%-9.31M

-330.13%-8.78M

-98.29%-4.18M

---5.45M

---2.18M

---2.04M

---2.11M

Net income from continuous operations

-290.15%-16.32M

-163.66%-14.37M

-327.46%-9.31M

-330.13%-8.78M

-98.29%-4.18M

---5.45M

---2.18M

---2.04M

---2.11M

Net income attributable to controlling interests

-290.15%-16.32M

-163.66%-14.37M

-327.46%-9.31M

-330.13%-8.78M

-98.29%-4.18M

---5.45M

---2.18M

---2.04M

---2.11M

Net income attributable to common shareholders

-290.15%-16.32M

-163.66%-14.37M

-327.46%-9.31M

-330.13%-8.78M

-98.29%-4.18M

---5.45M

---2.18M

---2.04M

---2.11M

Basic earnings per share

-284.24%-0.75

-159.95%-0.66

-592.77%-0.71

-330.14%-0.41

-98.30%-0.20

---0.25

---0.10

Diluted earnings per share

-284.24%-0.75

-159.95%-0.66

-592.77%-0.71

-330.14%-0.41

-98.30%-0.20

---0.25

---0.10

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

